Clinical Trials Browser

OTHER × Non-Muscle Invasive Bladder Neoplasms × Epirubicin × Clear all

NCT06227065 2024-01-26

POLO

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02214602 2018-03-22

NMIBCIVT

Phase 4 Completed

Non-Muscle Invasive Bladder Neoplasms